Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.45 USD | +3.55% | +5.62% | +3.94% |
06-20 | JMP Securities Adjusts Price Target on Iovance Biotherapeutics to $23 From $25, Maintains Market Outperform Rating | MT |
06-11 | Iovance Biotherapeutics, Inc. Elects Frederick G. Vogt as Director | CI |
Official Publications
No official publication found
- Stock Market
- Equities
- IOVA Stock
- News Iovance Biotherapeutics, Inc.
- Official Publications